실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

9,268+프로그램
35+FDA 승인
4,079+모집 중
ADC 1068·Antibody 5456·CGT 2744차세대 추천 →·Data Tier →
9268프로그램35FDA 승인
38오늘 방문
949누적 방문
8122갱신 대기S–CData TierS/A/B차세대1068HER2 breast5456Antibody2744CGT→Psoriasis→NSCLC35FDA 승인
피드Data Tier차세대

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · Ebglyss혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

최근 활동

RSS →

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 4,087개
다음 갱신 D-9 · 마지막 7월 13일
AntibodystaleGeorgetown UniversityPhase 1

Lenalidomide, Ibrutinib, Rituximab (Lenalidomide, Ibrutinib, Rituximab)

Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma · Chronic Lymphocytic Leukemia

#ChronicLymphocyticLeukemia#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleA.O. Ospedale Papa Giovanni XXI…Approved

fludarabine, cyclophosphamide, doxorubicin, rituximab (fludarabine, cyclophosphamide, doxorubicin, rituximab)

Post-transplant Lymphoproliferative Disease (PTLD); Non Burkitt · Post-transplant Lymphoproliferative Dise

#Post-transplantLymphoproliferati#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleCopenhagen University Hospital …Phase 3

Dexamethasone and Rituximab (Dexamethasone and Rituximab)

Idiopathic Thrombocytopenic Purpura · Idiopathic Thrombocytopenic Purpura

#IdiopathicThrombocytopenicPurpur#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleUniversity of California, San F…Phase 1

Velcade (Velcade, Velcade (bortezomib), rituximab, ifosfamide, carboplatin, etoposide, bortezomib)

Non-Hodgkin's Lymphoma; B-cell Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase1#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleRochePhase 2

rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin (rituximab, cytarabine, dexamethasone, and oxaliplatin/carboplatin)

Diffuse Large B-Cell Lymphoma; Follicular Lymphoma · Diffuse Large B-Cell Lymphoma

#DiffuseLargeB-CellLymphoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab, thalidomide and dexamethasone)

Relapse and / or Refractory Myeloma · FRα

#FR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 2

daratumumab (Darzalex, Daratumumab plus chemotherapy according to the national treatment program)

T-Lymphocytic Leukemia, Acute · T-Lymphocytic Leukemia, Acute

#T-LymphocyticLeukemiaAcute#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleGrupo Español de Linfomas y Tra…Phase 2

Ybritumomab Tiuxetan (Zevalin, Ybritumomab Tiuxetan, Ybritumomab Tiuxetan (Zevalin); Rituximab; BEAM (BCNU, ARAC, VP16 and Melphalan))

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

DRD (daratumumab/lenalidomide/dexamethasone, daratumumab/lenalidomide/dexamethasone (DRD))

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 2

Cetuximab Plus P-HDFL (Cetuximab Plus P-HDFL)

Gastric Cancer · Gastric Cancer

#GastricCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleFondazione Policlinico Universi…Phase 2

encorafenib + cetuximab + FOLFIRI (encorafenib + cetuximab + FOLFIRI)

Colorectal Carcinoma; Colorectal Neoplasms · Colorectal Carcinoma

#ColorectalCarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleShanghai Ninth People's Hospita…Phase 2

Dalpicilib combined with cetuximab (Dalpicilib combined with cetuximab)

Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma · Recurrent/Metastatic Head and Neck Squam

#RecurrentMetastaticHeadandNeckSq#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleXinqiao Hospital of ChongqingPhase 2

Thalidomide+cetuximab+FOLFOX/FOLFIRI (Thalidomide+cetuximab+FOLFOX/FOLFIRI)

Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer · Thalidomide Enhances Clinical Efficacy o

#ThalidomideEnhancesClinicalEffic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

Erbitux, C225 (Cetuximab, Cetuximab (Erbitux, C225))

Colorectal Cancer Metastatic · Colorectal Cancer Metastatic

#ColorectalCancerMetastatic#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleUniversity of Texas Southwester…Phase 2

cisplatin, cetuximab, or carboplatin-paclitaxel (cisplatin, cetuximab, or carboplatin-paclitaxel)

Head and Neck Cancer · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleVerastem, Inc.Phase 2

pembrolizumab (Keytruda, Carboplatin + Pemetrexed + Pembrolizumab)

Pancreatic Ductal Adenocarcinoma; Non Small Cell Lung Cancer · Pancreatic Ductal Adenocarcinoma

#PancreaticDuctalAdenocarcinoma#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleDaiichi SankyoPhase 1

Patritumab (Patritumab)

Squamous Cell Carcinoma of the Head and Neck · Squamous Cell Carcinoma of the Head and

#SquamousCellCarcinomaoftheHeadan#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 ACTIVE
AntibodystaleBenaroya Research InstitutePhase 2

Panitumumab or Cetuximab (Anti-EGFR, Anti-EGFR (Panitumumab or Cetuximab))

Colorectal Cancer; Cholangiocarcinoma · EGFR

#EGFR#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab and Erlotinib (Bevacizumab and Erlotinib)

Cancer · Cancer

#Cancer#Antibody#Phase2#항체#면역항체+2
효능 ORR 24%임상시험 1상태 ACTIVE
AntibodystaleEli LillyPhase 2

Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan (Cetuximab, Oxaliplatin, Leucovorin, 5FU, Irinotecan)

Metastatic Colorectal Cancer · Metastatic Colorectal Cancer

#MetastaticColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGenentech, Inc.Phase 1

MetMAb (MetMAb)

Solid Cancers · Solid Cancers

#SolidCancers#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

Bevacizumab plus erlotinib (Bevacizumab plus erlotinib)

Carcinoma, Non-Small-Cell Lung; Brain Neoplasms · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#Antibody#Phase2#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

oxaliplatin+capecitabine+bevacizumab+PD-1 antibody (oxaliplatin+capecitabine+bevacizumab+PD-1 antibody)

Colorectal Cancer; RAS Mutation · PD-1

#PD-1#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 ACTIVE
AntibodystaleBeiGenePhase 2

Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine (Tislelizumab+Bevacizumab+Oxaliplatin+Capecitabine)

Tislelizumab; Bevacizumab · Tislelizumab

#Tislelizumab#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleRochePreclinical

Bevacizumab Combined With PD-1 Monoclonal Antibody (Bevacizumab Combined With PD-1 Monoclonal Antibody)

Colorectal Cancer · PD-1

#PD-1#Antibody#Preclinical#항체#면역항체+3
임상시험 1상태 ACTIVE

104 / 164 페이지

← 이전다음 →
전체 9,268개 프로그램 보기